Camtek (CAMT) director details shares, options and RSUs in Form 3

Rhea-AI Filing Summary

Camtek Ltd. director Orit Stav filed an initial statement of beneficial ownership, outlining current holdings in ordinary shares and stock options. The filing shows direct ownership of ordinary shares and several option grants over Camtek ordinary shares with different exercise prices and maturities.

Fully vested and immediately exercisable stock options cover 3,176 ordinary shares at an exercise price of $22.6300 per share, alongside additional option grants over 880 shares at $63.5100, 1,132 shares at $81.2800, and 1,095 shares at $59.7600 per share, each with stated expiration dates through 2032. The filing also notes restricted stock units that convert into ordinary shares, with certain RSUs and options scheduled to vest on the date of Camtek’s 2026 annual meeting of shareholders, subject to continued service.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Stav Orit

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 3,176 shares (Direct); Ordinary Shares — 1,937 shares (Direct)

Footnotes (1)

1. These shares were issued upon vesting of previously granted restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Camtek Ltd. (the "Company"). The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs will vest on the date of the Company's 2026 annual meeting of shareholders, subject to continued service through the vesting date. The Stock Options are Fully vested and immediately exercisable The options will vest on the date of the Company's 2026 annual meeting of shareholders, subject to continued service through the vesting date.

Key Figures

Vested options underlying shares: 3,176 shares Exercise price (grant 1): $22.6300/share Options underlying shares (grant 2): 880 shares +4 more

7 metrics

Vested options underlying shares 3,176 shares Fully vested stock options over ordinary shares at $22.6300 exercise price

Exercise price (grant 1) $22.6300/share Stock Option (Right to Buy) expiring 2029-11-10

Options underlying shares (grant 2) 880 shares Stock options at $63.5100/share expiring 2030-12-21

Options underlying shares (grant 3) 1,132 shares Stock options at $81.2800/share expiring 2031-09-25

Options underlying shares (grant 4) 1,095 shares Stock options at $59.7600/share expiring 2032-04-29

Direct ordinary shares holding 1 1,937 shares Ordinary Shares, total shares following holding entry

Direct ordinary shares holding 2 628 shares Ordinary Shares, total shares following holding entry

Key Terms

Stock Option (Right to Buy), Restricted stock units ("RSUs"), contingent right to receive one ordinary share, annual meeting of shareholders, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" over Camtek ordinary shares"

Restricted stock units ("RSUs") financial

"These shares were issued upon vesting of previously granted restricted stock units ("RSUs")"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right to receive one ordinary share financial

"RSUs, which each represent a contingent right to receive one ordinary share of the Company"

annual meeting of shareholders financial

"will vest on the date of the Company's 2026 annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Fully vested and immediately exercisable financial

"The Stock Options are Fully vested and immediately exercisable"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Stav Orit

(Last) (First) (Middle)

5 URI ARIAV STREET

(Street)

ROSH HAAIN

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/13/2026

3. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	1,937(1)	D
Ordinary Shares	628(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	12/21/2023(3)	11/10/2029	Ordinary Shares	3,176	$22.63	D
Stock Option (Right to Buy)	09/25/2024(3)	12/21/2030	Ordinary Shares	880	$63.51	D
Stock Option (Right to Buy)	04/29/2025(3)	09/25/2031	Ordinary Shares	1,132	$81.28	D
Stock Option (Right to Buy)	(4)	04/29/2032	Ordinary Shares	1,095	$59.76	D

Explanation of Responses:

1. These shares were issued upon vesting of previously granted restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Camtek Ltd. (the "Company").

2. The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs will vest on the date of the Company's 2026 annual meeting of shareholders, subject to continued service through the vesting date.

3. The Stock Options are Fully vested and immediately exercisable

4. The options will vest on the date of the Company's 2026 annual meeting of shareholders, subject to continued service through the vesting date.

Remarks:

This Form 3 has been filed after March 18, 2026 but prior to April 20, 2026 in reliance on the temporary relief made available to the directors and officers of certain foreign private issuers by the Staff of the Securities and Exchange Commission in its no-action letter dated March 13, 2026.

	Orit Stav by: Oppenheimer Israel, as Attorney-in-fact	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Camtek (CAMT) director Orit Stav report on this Form 3?

The Form 3 shows initial beneficial ownership for director Orit Stav in Camtek. It lists direct holdings of ordinary shares plus multiple stock option grants over ordinary shares with specific exercise prices, expiration dates and vesting schedules, but no new buy or sell transactions.

How many Camtek (CAMT) shares are covered by Orit Stav’s vested stock options?

The filing shows fully vested, immediately exercisable options over 3,176 ordinary shares at an exercise price of $22.6300 per share. These options are currently exercisable and have an expiration date in 2029, defining part of Stav’s equity exposure.

What other Camtek (CAMT) stock options does Orit Stav hold?

Beyond the fully vested grant, Stav holds options over 880 shares at $63.5100, 1,132 shares at $81.2800, and 1,095 shares at $59.7600. These option awards have expiration dates between 2030 and 2032, with some subject to future vesting.

What ordinary share holdings of Camtek (CAMT) does the Form 3 disclose?

The Form 3 lists direct holdings of Camtek ordinary shares by Orit Stav. It shows separate entries with totals following the reported holdings, indicating a base level of common equity ownership alongside option and restricted stock unit positions.

How are RSUs described in Camtek (CAMT) director Orit Stav’s filing?

Footnotes explain that restricted stock units (RSUs) each represent a contingent right to receive one ordinary share of Camtek. Certain RSUs will vest on the date of the company’s 2026 annual meeting of shareholders, provided Stav continues in service through that vesting date.

Do any Camtek (CAMT) equity awards in this Form 3 depend on future service?

Yes. The filing states some RSUs and stock options will vest on the date of Camtek’s 2026 annual meeting of shareholders. Vesting is conditioned on Orit Stav’s continued service with the company through that meeting date.